![Ron Squarer](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Ron Squarer
Président chez
ADC THERAPEUTICS SA
Fortune : 5 M $ au 30/06/2026
Profil
Mr. Ron Squarer is an Independent Director at Nuvalent, Inc., a Chairman at ADC Therapeutics SA and an Independent Director at Travere Therapeutics, Inc. He is on the Board of Directors at Nuvalent, Inc., Travere Therapeutics, Inc. and Deciphera Pharmaceuticals LLC.
Mr. Squarer was previously employed as a Chairman by Deciphera Pharmaceuticals, Inc., a Chief Executive Officer & Director by Array BioPharma, Inc., a Chief Commercial Officer & Senior Vice President by Hospira, Inc., a SVP-Business Development & VP-Global Strategy by Mayne Pharma Ltd., and a Principal by Smithkline Beecham Plc.
He received his undergraduate degree from the University of California, Berkeley and an MBA from Kellogg School of Management.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 19/05/2026 | 39 375 ( 0,04 % ) | 2 M $ | 30/06/2026 | |
ADC THERAPEUTICS LTD 1,26 % | 03/06/2026 | 1 607 627 ( 1,26 % ) | 2 M $ | 30/06/2026 |
NUVALENT, INC. CLASS A 0,01 % | 16/06/2026 | 6 281 ( 0,01 % ) | 775 704 $ | 30/06/2026 |
Postes actifs de Ron Squarer
| Sociétés | Poste | Début |
|---|---|---|
| TRAVERE THERAPEUTICS, INC. | Directeur/Membre du Conseil | 12/04/2017 |
| ADC THERAPEUTICS SA | Président | 01/03/2020 |
| NUVALENT, INC. | Directeur/Membre du Conseil | 09/12/2025 |
Deciphera Pharmaceuticals LLC
 Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Directeur/Membre du Conseil | 01/12/2019 |
Anciens postes connus de Ron Squarer
| Sociétés | Poste | Fin |
|---|---|---|
| DECIPHERA PHARMACEUTICALS, INC. | Président | 11/06/2024 |
| ARRAY TECHNOLOGIES, INC. | Directeur Général | 01/08/2019 |
| HOSPIRA, INC. | Corporate Officer/Principal | 01/02/2012 |
Mayne Pharma Ltd.
 Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 01/01/2007 |
Smithkline Beecham Plc
 Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Corporate Officer/Principal | - |
Formation de Ron Squarer
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
45
Relations au 1er degré
11
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 11 |
|---|---|
Smithkline Beecham Plc
Smithkline Beecham Plc Pharmaceuticals: OtherHealth Technology Develops and manufactures pharmaceutical products | Health Technology |
Array BioPharma, Inc.
 Array BioPharma, Inc. Pharmaceuticals: MajorHealth Technology Develops & commercializes biopharmaceutical drugs | Health Technology |
Hospira, Inc.
 Hospira, Inc. Pharmaceuticals: MajorHealth Technology Provides drugs, IV sets and clinical integration & software, infusion pumps and implementation services | Health Technology |
University of California, Berkeley
 University of California, Berkeley Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Mayne Pharma Ltd.
Mayne Pharma Ltd. Pharmaceuticals: OtherHealth Technology Manufactures pharmaceutical products | Health Technology |
Deciphera Pharmaceuticals LLC
Deciphera Pharmaceuticals LLC BiotechnologyHealth Technology Discovers and develops pharmaceutical preparations | Health Technology |
ADC Therapeutics SA
 ADC Therapeutics SA Pharmaceuticals: MajorHealth Technology Develops proprietary antibody drug conjugates for the treatment of both solid and hematological cancers | Health Technology |
Travere Therapeutics, Inc.
 Travere Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company that engages in developing and delivering life-changing therapies to people living with rare kidney, liver & metabolic diseases | Health Technology |
Kellogg School of Management
 Kellogg School of Management Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Deciphera Pharmaceuticals, Inc.
 Deciphera Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops novel drug candidates to improve the lives of cancer patients | Health Technology |
Nuvalent, Inc.
 Nuvalent, Inc. Pharmaceuticals: MajorHealth Technology Engages in discovery, development and commercialization of targeted therapies for patients with cancer | Health Technology |
Choisissez Zonebourse 
